Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK
Bulletin of Pure & Applied Sciences- Zoology · 2023
DOI: 10.48165/bpas.2023.42a.1.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Pure & Applied Sciences- Zoology, 2023. Verfasst von Durgesh M Agase.
Abstract (Originalsprache)
The drawbacks of traditional chemotherapy include its inability to dissolve in water, lack of selectivity, and multidrug resistance. The use of anticancer peptides is a unique therapeutic approach against cancer cells. In this In-silico work, the kinase inhibition activity for both chosen target molecules (Flt3 and Lck protein) was evaluated in order to find a possible anti-leukemic spider venom peptide. Out of the 11 spider venom peptides, Lycosin-I peptide (from Lycosa singoriensis) for Lck and Latarcin 2a peptide (from Lachesana tarabaevi) for Flt3 were suggested as the best lead peptides for the creation of anti-leukemic drugs.
Zitieren
APA
Agase, D. M. (2023). Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK. Bulletin of Pure & Applied Sciences- Zoology. https://doi.org/10.48165/bpas.2023.42a.1.13
Vancouver
Agase DM. Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK. Bulletin of Pure & Applied Sciences- Zoology. 2023. doi:10.48165/bpas.2023.42a.1.13
BibTeX
@article{Agase2023,
author = {Agase, Durgesh M},
title = {Screening of Spider Venom Peptides and Molecular Docking of FLT3 and LCK},
journal = {Bulletin of Pure & Applied Sciences- Zoology},
year = {2023},
doi = {10.48165/bpas.2023.42a.1.13}
}
EUVIMED